The structure and synthesis of influenza virus phosphoproteins
- PMID: 7240143
The structure and synthesis of influenza virus phosphoproteins
Abstract
The synthesis and phosphorylation of influenza virus nucleoprotein and nonstructural protein were analyzed. The nucleoprotein (NP) was found to be phosphorylated in both infected cells and in isolated virions. The phosphate is in a monoester linkage to a serine residue. Two-dimensional tryptic peptide maps of the 32P-labeled protein, as well as measurements of specific activity, suggests that NP is phosphorylated at one site per molecule. The viral nonstructural (NS 1) protein is also phosphorylated, but on threonine residues. Up to a maximum of two sites per NS 1 molecule could be so modified in infected cells, as demonstrated by two different methods of tryptic peptide analysis and by measurements of the ratio of 32P to 3H-amino-acids incorporated into NS 1 protein species. The NS 1 protein is resolved into four major species of differing isoelectric point in a two-dimensional electrophoretogram. The most acidic species was found to have two phosphorylated sites per molecule, and the next most acidic species contained on the average one phosphate per molecule. Treatment of the phosphorylated species with bacterial alkaline phosphatase demonstrated that the level of phosphorylation is the only identifiable difference between the phosphorylated and unphosphorylated NS 1 species. The distinction between the two unphosphorylated species could not be determined. The distribution of the un-, mono-, and diphosphorylated NS 1 species was characterized at different times after synthesis. These modifications were found to occur very rapidly after translation (30 to 60 s), after transport of the unmodified species from cytoplasm to nucleus of the infected cell. The phosphorylation of NP also takes place rapidly after its synthesis; the site within the cell of the NP phosphorylation has not been unambiguously determined.
Similar articles
-
Identification of influenza C virus phosphoproteins.Microbiol Immunol. 1995;39(9):737-40. doi: 10.1111/j.1348-0421.1995.tb03251.x. Microbiol Immunol. 1995. PMID: 8577290
-
Phosphorylation of vesicular stomatitis virus in vivo and in vitro.J Virol. 1974 Feb;13(2):455-65. doi: 10.1128/JVI.13.2.455-465.1974. J Virol. 1974. PMID: 4359301 Free PMC article.
-
Phosphorylation of the nucleoprotein of an avian influenza virus.J Gen Virol. 1982 Jun;60(Pt 2):295-305. doi: 10.1099/0022-1317-60-2-295. J Gen Virol. 1982. PMID: 7108489
-
cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets.J Biol Chem. 1994 May 20;269(20):14509-17. J Biol Chem. 1994. PMID: 8182057
-
Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75.J Virol. 1996 Jun;70(6):3385-91. doi: 10.1128/JVI.70.6.3385-3391.1996. J Virol. 1996. PMID: 8648669 Free PMC article.
Cited by
-
The membrane (M1) protein of influenza virus occurs in two forms and is a phosphoprotein.J Virol. 1984 Jan;49(1):229-35. doi: 10.1128/JVI.49.1.229-235.1984. J Virol. 1984. PMID: 6690712 Free PMC article.
-
SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization.J Virol. 2013 May;87(10):5602-20. doi: 10.1128/JVI.02063-12. Epub 2013 Mar 6. J Virol. 2013. PMID: 23468495 Free PMC article.
-
The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A).J Virol. 1994 Apr;68(4):2425-32. doi: 10.1128/JVI.68.4.2425-2432.1994. J Virol. 1994. PMID: 7908060 Free PMC article.
-
CK2beta gene silencing increases cell susceptibility to influenza A virus infection resulting in accelerated virus entry and higher viral protein content.J Mol Signal. 2008 Jul 23;3:13. doi: 10.1186/1750-2187-3-13. J Mol Signal. 2008. PMID: 18651975 Free PMC article.
-
Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions.Front Immunol. 2018 Apr 12;9:743. doi: 10.3389/fimmu.2018.00743. eCollection 2018. Front Immunol. 2018. PMID: 29755452 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous